180 related articles for article (PubMed ID: 38056296)
1. Small molecules targeting selected histone methyltransferases (HMTs) for cancer treatment: Current progress and novel strategies.
Li D; Peng X; Hu Z; Li S; Chen J; Pan W
Eur J Med Chem; 2024 Jan; 264():115982. PubMed ID: 38056296
[TBL] [Abstract][Full Text] [Related]
2. Discovery of cysteine-targeting covalent histone methyltransferase inhibitors.
Zhao Y; Jiang B; Gu Z; Chen T; Yu W; Liu S; Liu X; Chen D; Li F; Chen W
Eur J Med Chem; 2023 Jan; 246():115028. PubMed ID: 36528996
[TBL] [Abstract][Full Text] [Related]
3. Exploring Methods of Targeting Histone Methyltransferases and Their Applications in Cancer Therapeutics.
Wang MY; Liow P; Guzman MIT; Qi J
ACS Chem Biol; 2022 Apr; 17(4):744-755. PubMed ID: 35363464
[TBL] [Abstract][Full Text] [Related]
4. Cancer drug discovery targeting histone methyltransferases: an update.
Zhao H; Wang Y; Li H
Curr Med Chem; 2015; 22(17):2075-86. PubMed ID: 25850768
[TBL] [Abstract][Full Text] [Related]
5. Integrated Analysis of Genetic Abnormalities of the Histone Lysine Methyltransferases in Prostate Cancer.
Zhang Y; Yan L; Yao W; Chen K; Xu H; Ye Z
Med Sci Monit; 2019 Jan; 25():193-239. PubMed ID: 30616239
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells.
Kondo Y; Shen L; Ahmed S; Boumber Y; Sekido Y; Haddad BR; Issa JP
PLoS One; 2008 Apr; 3(4):e2037. PubMed ID: 18446223
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of histone methyltransferases in breast cancer - Opportunities for new targeted therapies?
Michalak EM; Visvader JE
Mol Oncol; 2016 Dec; 10(10):1497-1515. PubMed ID: 27717710
[TBL] [Abstract][Full Text] [Related]
8. Interaction between DNA/histone methyltransferases and their inhibitors.
Hu J; Chen S; Kong X; Zhu K; Cheng S; Zheng M; Jiang H; Luo C
Curr Med Chem; 2015; 22(3):360-72. PubMed ID: 25386815
[TBL] [Abstract][Full Text] [Related]
9. Recent progress in the discovery of epigenetic inhibitors for the treatment of cancer.
Verma SK
Methods Mol Biol; 2015; 1238():677-88. PubMed ID: 25421686
[TBL] [Abstract][Full Text] [Related]
10. Role and potential therapeutic value of histone methyltransferases in drug resistance mechanisms in lung cancer.
Zhang L; Zhang X; Shi Y; Ni Y; Fei J; Jin Z; Li W; Wang X; Wu N
Front Oncol; 2024; 14():1376916. PubMed ID: 38525426
[TBL] [Abstract][Full Text] [Related]
11. Chemical probes of histone lysine methyltransferases.
Kaniskan HÜ; Jin J
ACS Chem Biol; 2015 Jan; 10(1):40-50. PubMed ID: 25423077
[TBL] [Abstract][Full Text] [Related]
12. Assay development for histone methyltransferases.
Horiuchi KY; Eason MM; Ferry JJ; Planck JL; Walsh CP; Smith RF; Howitz KT; Ma H
Assay Drug Dev Technol; 2013 May; 11(4):227-36. PubMed ID: 23557020
[TBL] [Abstract][Full Text] [Related]
13. An update on allosteric modulators as a promising strategy targeting histone methyltransferase.
Tan Z; Li T; Lei H; Zhai X
Pharmacol Res; 2021 Oct; 172():105865. PubMed ID: 34474102
[TBL] [Abstract][Full Text] [Related]
14. Histone lysine methyltransferases as anti-cancer targets for drug discovery.
Liu Q; Wang MW
Acta Pharmacol Sin; 2016 Sep; 37(10):1273-1280. PubMed ID: 27397541
[TBL] [Abstract][Full Text] [Related]
15. Dietary Flavones as Dual Inhibitors of DNA Methyltransferases and Histone Methyltransferases.
Kanwal R; Datt M; Liu X; Gupta S
PLoS One; 2016; 11(9):e0162956. PubMed ID: 27658199
[TBL] [Abstract][Full Text] [Related]
16. A coupled fluorescent assay for histone methyltransferases.
Collazo E; Couture JF; Bulfer S; Trievel RC
Anal Biochem; 2005 Jul; 342(1):86-92. PubMed ID: 15958184
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of peptide-MCA substrates for a novel assay of histone methyltransferases and their inhibitors.
Chi H; Takemoto Y; Nsiama TK; Kato T; Nishino N; Ito A; Yoshida M
Bioorg Med Chem; 2014 Feb; 22(4):1268-75. PubMed ID: 24486204
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence-based methods for screening writers and readers of histone methyl marks.
Allali-Hassani A; Wasney GA; Siarheyeva A; Hajian T; Arrowsmith CH; Vedadi M
J Biomol Screen; 2012 Jan; 17(1):71-84. PubMed ID: 21972038
[TBL] [Abstract][Full Text] [Related]
19. Biochemical Assay Development for Histone Methyltransferases Using a Transcreener-Based Assay for S-Adenosylhomocysteine.
Kumar M; Zielinski T; Lowery RG
Assay Drug Dev Technol; 2015 May; 13(4):200-9. PubMed ID: 25710335
[TBL] [Abstract][Full Text] [Related]
20. The HPV E6 oncoprotein targets histone methyltransferases for modulating specific gene transcription.
Hsu CH; Peng KL; Jhang HC; Lin CH; Wu SY; Chiang CM; Lee SC; Yu WC; Juan LJ
Oncogene; 2012 May; 31(18):2335-49. PubMed ID: 21963854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
